Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Review of Alzheimer’s Association International Conference (AAIC16) Part 2: Focus on Secretases

Posted on August 24th, 2016 by in Pharma R&D

In a previous blog, I provided a few thoughts on tau-related drug discovery news coming out of the recent Alzheimer’s Association International Conference (AAIC16) in Toronto, Canada. In this post, I will highlight some of the research from the conference on gamma and beta-secretase, Continue reading “Review of Alzheimer’s Association International Conference (AAIC16) Part 2: Focus on Secretases” »

Reaching Out to Potential Drug Trial Participants

Posted on August 15th, 2016 by in Pharma R&D

Product testing is a necessary step in almost any industry, but in the pharmaceutical world, testing the safety and efficacy of drugs isn’t just a matter of getting a few people to ‘try it out’ – it’s a massive, tightly-regulated effort requiring extensive drug trials that include hundreds or thousands of participants. Continue reading “Reaching Out to Potential Drug Trial Participants” »

The 10 most talked-about journal articles about Alzheimer’s Disease

Posted on August 2nd, 2016 by in Pharma R&D

The Alzheimer’s Association International Conference just wrapped up in Toronto, Canada (Patrick May was there and will be writing all about it). In honor of the conference, here is a list of Alzheimer’s-related journal articles that were most-talked about in the last month in social media, blogs, and news coverage. Continue reading “The 10 most talked-about journal articles about Alzheimer’s Disease” »